These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28381434)

  • 1. Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for
    Catanzaro DG; Trollip AP; Seifert M; Georghiou SB; Garfein RS; Rodwell TC; Catanzaro A; Eisenach KD
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28381434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of MODS assay for rapid detection of Mycobacterium tuberculosis resistance to second-line drugs in a tertiary care tuberculosis hospital in China.
    Huang Z; Li G; Chen J; Li W; Xu X; Luo Q; Xiong G; Sun J; Li J
    Tuberculosis (Edinb); 2014 Sep; 94(5):506-10. PubMed ID: 25082461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microscopic observation drug susceptibility (MODS): where are we going?
    Kam KM
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):127. PubMed ID: 24429301
    [No Abstract]   [Full Text] [Related]  

  • 4. [Consideration on the use of injectable anti-tuberculosis drufgs in the treatment of drug-resistant tuberculosis in china].
    Liu YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):401-404. PubMed ID: 31189224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New generation methods for drug susceptibility testing for tuberculosis.
    Katoch VM
    Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line antituberculous drugs: results from two centers.
    Coban AY; Martin A; Uzun M; Bilgin K; Palomino JC; Durupinar B
    J Chemother; 2008 Jun; 20(3):388-90. PubMed ID: 18606599
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
    Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):502-9. PubMed ID: 21396210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The analysis of clinical data about the treatment of linezolid against tuberculosis].
    Nie WJ; Chu NH
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):601-3. PubMed ID: 24252739
    [No Abstract]   [Full Text] [Related]  

  • 11. Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis.
    Rasslan O; Hafez SF; Hashem M; Ahmed OI; Faramawy MA; Khater WS; Saleh DA; Mohamed MI; Khalifa MA; Shoukry FA; El-Moghazy EH
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):941-6. PubMed ID: 22584201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali.
    Sanogo M; Kone B; Diarra B; Maiga M; Baya B; Somboro AM; Sarro YS; Togo ACG; Dembele BPP; Goita D; Kone A; M'Baye O; Coulibaly N; Diabate S; Traore B; Diallo MH; Coulibaly YI; Saleeb P; Belson M; Orsega S; Siddiqui S; Polis MA; Dao S; Murphy RL; Diallo S
    Clin Microbiol Infect; 2017 Jun; 23(6):408.e1-408.e6. PubMed ID: 28110049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.
    Shiferaw G; Woldeamanuel Y; Gebeyehu M; Girmachew F; Demessie D; Lemma E
    J Clin Microbiol; 2007 Apr; 45(4):1093-7. PubMed ID: 17251409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant tuberculosis: resistance rates to first and reserve antituberculosis drugs in the UK in 2008/9 and the role of rapid molecular tests for drug resistance.
    Mitchell SL; Seoudi N; Hutchison DC; Drobniewski FA
    Thorax; 2011 Jul; 66(7):630-1. PubMed ID: 20880876
    [No Abstract]   [Full Text] [Related]  

  • 15. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of microscopic observation drug susceptibility for drug susceptibility testing of mycobacterium tuberculosis in smear-positive sputum].
    Lu JM; Wang J; Huang XC; Hu ZY; Cui ZL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):21-5. PubMed ID: 21418814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
    N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis].
    Gui XH; Xu P; Zhao M; Wang LL; Wu J; Li J; Gao Q; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):43-5. PubMed ID: 20368024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015.
    Dalcolmo M; Gayoso R; Sotgiu G; D'Ambrosio L; Rocha JL; Borga L; Fandinho F; Braga JU; Arakaki Sanchez D; Dockhorn F; Centis R; Migliori GB
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.